Company Encyclopedia
View More
name
HTG Molecular Diagnostics, Inc.
HTGMQ.US
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel.
65.98 B
HTGMQ.USMarket value -Rank by Market Cap -/-

Financial Score

28/12/2025 Update
E
Health Care TechnologyIndustry
Industry Ranking46/46
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-343.21%E
    • Profit Margin-324.28%E
    • Gross Margin-167.52%E
  • Growth ScoreE
    • Revenue YoY-28.21%E
    • Net Profit YoY-7.22%C
    • Total Assets YoY-61.83%E
    • Net Assets YoY-95.79%E
  • Cash ScoreD
    • Cash Flow Margin-30.84%D
    • OCF YoY-28.21%E
  • Operating ScoreD
    • Turnover0.32D
  • Debt ScoreE
    • Gearing Ratio95.63%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    © 2025 Longbridge｜Disclaimer